Buyer for a regulatory CRO in Europe

Company to buy

Size: Small to medium business
Sales: 5-20 million EUR
Location: Europe
Reason for acquisition: The management wants to expand their business to Europe
#CFIE PHB226

Overview of buyer for a regulatory CRO in Europe

A CRO company with almost 10 years of experience in the industry is for sale. Further, the company offers regulatory and quality consultancy services and is a full-service CRO. Of primary importance, the company is backed by a PE fund. Currently, they are actively looking for companies in Europe to expand their activities in the region.

Profile (strategy) of buyer for a regulatory CRO in Europe

Significantly, this regulatory CRO is a leading provider of full-service regulatory support services to pharmaceutical and biotech companies in Europe. Above all, with expertise in a wide range of therapeutic areas, the CRO provides a single point of contact for all regulatory needs.

Notably, the company is an international company staffed with skilled professionals from the medical device and pharmaceutical sectors, spanning clinical research and the regulatory domain. Altogether, the group offers regulatory support, digital solutions, and comprehensive CRO support. Most importantly, these are tailored toward innovation, continuous enhancement, scalability, and personalization.

Critically, the CRO has a strong track record of success in helping clients navigate the complex regulatory landscape. Foundationally, they have a deep understanding of the regulatory requirements for a variety of therapeutic areas. Consequently, the CRO can help clients achieve their regulatory goals. For example, some of the therapeutic areas where the CRO has expertise are oncology, cardiology, central nervous system (CNS), rare diseases, and immunology.

Financially, the CRO is well-funded and has a strong fiscal position with backing from a PE fund. As a result, this ensures that it has the resources it needs to continue to grow and succeed.

Subscribe as an interested seller
Contact us to get details about this buyer for a regulatory CRO in Europe

Activities and products of suitable targets

Preferably, the target company should have robust financial performance, with a favorable EBITDA margin. Further, the target should be in the field of regulatory services for clinical studies. Overall, the company is looking for a well-positioned CRO in Europe.

Highlights

Strong track record of success in regulatory affairs, with a proven ability to help clients navigate the complex regulatory landscape
Well-funded and has a strong financial position
Team of experienced professionals with a deep understanding of the regulatory landscape

More information on this buyer for a regulatory CRO in Europe

Please get in touch if you are interested in learning more about this buyer for a regulatory CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CRO buyer

Please use a company e-mail address. No Hotmail/Yahoo/Googlemail etc.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a real opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy, and fit with the target. There is also a possibility that your details will be kept on file, and we will get back to you once there is an opportunity to do a transaction. CFIE cannot guarantee you will receive an answer to your request.